| Date Filed | Type | Description |
| 08/15/2023 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 8.2% stake in IO Biotech, Inc. |
| 08/14/2023 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 6.1% stake in IO Biotech, Inc. |
| 02/14/2023 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 8.7% stake in Y-mAbs Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 3.6% stake in Harmony Biosciences Holdings, Inc. |
| 02/14/2023 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 3.1% stake in Ambrx Biopharma Inc. |
| 02/14/2023 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 10% stake in Longboard Pharmaceuticals, Inc. |
| 02/11/2022 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 4% stake in BioAtla, Inc. |
| 02/11/2022 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 6.9% stake in Ambrx Biopharma Inc. |
| 02/11/2022 |
SC 13G
| HBM Healthcare Investments Ltd. reports a 8.4% stake in IO Biotech, Inc. |
| 02/11/2022 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 0% stake in Galecto, Inc. |
| 02/11/2022 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 7.8% stake in Harmony Biosciences Holdings, Inc. |
| 02/07/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 07/02/2021 |
SC 13G
| HBM Healthcare Investments Ltd. reports a 6.7% stake in Ambrx Biopharma, Inc. |
| 03/22/2021 |
SC 13G
| HBM Healthcare Investments Ltd. reports a 10% stake in Longboard Pharmaceuticals, Inc. |
| 02/12/2021 |
SC 13G
| HBM Healthcare Investments Ltd. reports a 8.2% stake in Harmony Biosciences Holdings, Inc. |
| 02/12/2021 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 5.3% stake in Y-mAbs Therapeutics, Inc. |
| 02/12/2021 |
SC 13G
| HBM Healthcare Investments Ltd. reports a 5.2% stake in Galecto, Inc. |
| 12/28/2020 |
SC 13G
| HBM Healthcare Investments Ltd. reports a 8.8% stake in BioAtla, Inc. |
| 02/11/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/01/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 3.5% stake in Principia Biopharma Inc. |
| 02/14/2019 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 8.2% stake in Y-mAbs Therapeutics, Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/01/2018 |
SC 13G
| HBM Healthcare Investments Ltd. reports a 9% stake in Y-mAbs Therapeutics, Inc. |
| 09/27/2018 |
SC 13G
| HBM Healthcare Investments Ltd. reports a 5.3% stake in Principia Biopharma Inc. |
| 03/16/2018 |
SC 13G
| HBM Healthcare Investments Ltd. reports a 5.4% stake in ARMO BioSciences, Inc. |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 5.5% stake in EIGER BIOPHARMACEUTICALS, INC. |
| 02/14/2018 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 6.2% stake in ObsEva SA |
| 10/10/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|